VALN - Valneva reports FY results; issues FY23 guidance
- Valneva press release ( NASDAQ: VALN ): FY cash and cash equivalents were €289.4 million as of December 31, 2022, compared to €346.7 million as of December 31, 2021.
- Revenue of €361.3M (+3.8% Y/Y).
-
Full year 2023 sales guidance : €130 million to €150 million product sales, including marginal COVID-19 vaccine sales under an existing supply agreement with the Kingdom of Bahrain.
For further details see:
Valneva reports FY results; issues FY23 guidance